BIT 2.22% 4.6¢ biotron limited

Commercial transactions

  1. 34,330 Posts.
    lightbulb Created with Sketch. 9057
    Today’s annual report state:

    “The Company is now fully focused on achieving commercial transaction(s) for the Company’s portfolio of antiviral programs.”


    MM has put $300k into the company by converting 2m of 15c options (expires 30 November 2018).
    She could buy BIT at 4c after the results announcement just two weeks ago, but she converted November options at bout 4 time price.
    Maybe she is subject to blackperiod, can’t buy at the moment, due to briefing to potential pharmaceutical partners?

    MM will be presenting at Australia Biotech Invest & Partnering 2018 on 30 October: 75B0BA0C-5B27-4A20-B4DD-D01BA054ABEF.jpeg DE39E166-843E-4E0C-81EC-4F2C64CE6B1E.jpeg
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.